<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kalpongnukul N</submitter><funding>Development and Promotion of Science and Technology</funding><funding>Chulalongkorn University</funding><funding>Office of the Higher Education Commission</funding><funding>Institute for the Promotion of Teaching Science and Technology</funding><funding>Thailand Research Fund</funding><funding>National Research Council of Thailand</funding><pagination>2893-2904</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9724709</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(12)</volume><pubmed_abstract>Glioblastoma (GBM) is a devastating primary brain cancer with a poor prognosis. GBM is associated with an abnormal mechanistic target of rapamycin (mTOR) signaling pathway, consisting of two distinct kinase complexes: mTORC1 and mTORC2. The complexes play critical roles in cell proliferation, survival, migration, metabolism, and DNA damage response. This study investigated the aberrant mTORC2 signaling pathway in GBM cells by performing quantitative phosphoproteomic analysis of U87MG cells under different drug treatment conditions. Interestingly, a functional analysis of phosphoproteome revealed that mTORC2 inhibition might be involved in double-strand break (DSB) repair. We further characterized the relationship between mTORC2 and BRISC and BRCA1-A complex member 1 (BABAM1). We demonstrat</pubmed_abstract><journal>Journal of proteome research</journal><pubmed_title>Phosphoproteomic Analysis Defines BABAM1 as mTORC2 Downstream Effector Promoting DNA Damage Response in Glioblastoma Cells.</pubmed_title><pmcid>PMC9724709</pmcid><funding_grant_id>RA62/075</funding_grant_id><funding_grant_id>026/2015</funding_grant_id><funding_grant_id>MRG6180215</funding_grant_id><pubmed_authors>Kaewsapsak P</pubmed_authors><pubmed_authors>Wongkongkathep P</pubmed_authors><pubmed_authors>Pisitkun T</pubmed_authors><pubmed_authors>Chantaravisoot N</pubmed_authors><pubmed_authors>Kalpongnukul N</pubmed_authors><pubmed_authors>Bootsri R</pubmed_authors><pubmed_authors>Ariyachet C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phosphoproteomic Analysis Defines BABAM1 as mTORC2 Downstream Effector Promoting DNA Damage Response in Glioblastoma Cells.</name><description>Glioblastoma (GBM) is a devastating primary brain cancer with a poor prognosis. GBM is associated with an abnormal mechanistic target of rapamycin (mTOR) signaling pathway, consisting of two distinct kinase complexes: mTORC1 and mTORC2. The complexes play critical roles in cell proliferation, survival, migration, metabolism, and DNA damage response. This study investigated the aberrant mTORC2 signaling pathway in GBM cells by performing quantitative phosphoproteomic analysis of U87MG cells under different drug treatment conditions. Interestingly, a functional analysis of phosphoproteome revealed that mTORC2 inhibition might be involved in double-strand break (DSB) repair. We further characterized the relationship between mTORC2 and BRISC and BRCA1-A complex member 1 (BABAM1). We demonstrat</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-05T11:53:28.552Z</modification><creation>2025-04-05T11:53:28.552Z</creation></dates><accession>S-EPMC9724709</accession><cross_references><pubmed>36315652</pubmed><doi>10.1021/acs.jproteome.2c00240</doi></cross_references></HashMap>